mitigates microvascular complications of type 2 diabetes mellitus: the involvement of oxidative stress and aldose reductase.

Objectives: () tubers are used in the management of diabetes. This research evaluated the effect of ethylacetate extract of (EACA) on microvascular complications and the possible association of oxidative stress and aldose reductase in type 2 diabetic rats.

Methods: tubers were subjected to sequential extraction until ethylacetate extract was obtained using a soxhlet apparatus.

mitigates microvascular complications of type 2 diabetes mellitus: the involvement of oxidative stress and aldose reductase.

Objectives: () tubers are used in the management of diabetes. This research evaluated the effect of ethylacetate extract of (EACA) on microvascular complications and the possible association of oxidative stress and aldose reductase in type 2 diabetic rats.

Methods: tubers were subjected to sequential extraction until ethylacetate extract was obtained using a soxhlet apparatus.

Antihyperglycaemic activity of ethylacetate extract of Chlorophytum alismifolium in type 2 diabetes: The involvement of peroxisome proliferator-activated receptor-γ and dipeptidyl peptidase-4.

Objective: This research is to investigate the antihyperglycaemic activity and the underlying mechanisms of action of the ethylacetate extract of Chlorophytum alismifolium (EACA) tubers in a type 2 diabetes model.

Methods: The tubers were processed and sequentially extracted in hexane followed by ethylacetate, using a Soxhlet apparatus, and subjected to gas chromatography-mass spectrometry (GC-MS). The acute toxicity of EACA was investigated in albino Wistar rats.